| 1 |
Carvalho AF, Firth J, Vieta E. Bipolar disorder[J]. N Engl J Med, 2020, 383(1): 58-66.
|
| 2 |
Anderson IM, Haddad PM, Scott J. Bipolar disorder[J]. BMJ, 2012, 345: e8508.
|
| 3 |
Tondo L, Vázquez GH, Baldessarini RJ. Depression and mania in bipolar disorder[J]. Curr Neuropharmacol, 2017, 15(3): 353-358.
|
| 4 |
He H, Hu C, Ren Z, et al. Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: results from the global burden of disease study 2017[J]. J Psychiatr Res, 2020, 125: 96-105.
|
| 5 |
Kudoh A, Katagai H, Takase H, et al. Effect of preoperative discontinuation of antipsychotics in schizophrenic patients on outcome during and after anaesthesia[J]. Eur J Anaesthesiol, 2004, 21(5): 414-416.
|
| 6 |
Gitlin MJ. Antidepressants in bipolar depression: an enduring controversy[J]. Int J Bipolar Disord, 2018, 6(1): 25.
|
| 7 |
Viktorin A, Lichtenstein P, Thase ME, et al. The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer[J]. Am J Psychiatry, 2014, 171(10): 1067-1073.
|
| 8 |
王嘉薇, 尚靖, 陈嘉. 抗抑郁药物治疗双相情感障碍的研究进展[J]. 现代药物与临床, 2021, 36(3): 628-632.
|
|
Wang JW, Shang J, Chen J. Research progress of antidepressant therapy for bipolar disorder[J]. Drugs Clin, 2021, 36(3): 628-632.
|
| 9 |
Catalani B, Hamilton CS, Herron EW, et al. Psychiatric agents and implications for perioperative analgesia[J]. Best Pract Res Clin Anaesthesiol, 2014, 28(2): 167-181.
|
| 10 |
Copeland LA, Zeber JE, Pugh MJ, et al. Postoperative complications in the seriously mentally ill: a systematic review of the literature[J]. Ann Surg, 2008, 248(1): 31-38.
|
| 11 |
Naguib M, Koorn R. Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management[J]. CNS Drugs, 2002, 16(4): 229-247.
|
| 12 |
Elvir-Lazo OL, White PF, Cruz Eng H, et al. Impact of chronic medications in the perioperative period-anesthetic implications (PartⅡ)[J]. Postgrad Med, 2021, 133(8): 920-938.
|
| 13 |
Fakra E, Azorin JM. Clozapine for the treatment of schi-zophrenia[J]. Expert Opin Pharmacother, 2012, 13(13): 1923-1935.
|
| 14 |
Werner FM, Coveñas R. Safety of antipsychotic drugs: focus on therapeutic and adverse effects[J]. Expert Opin Drug Saf, 2014, 13(8): 1031-1042.
|
| 15 |
De Hert M, Detraux J, van Winkel R, et al. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs[J]. Nat Rev Endocrinol, 2011, 8(2): 114-126.
|
| 16 |
Kudoh A. Perioperative management for chronic schizophrenic patients[J]. Anesth Analg, 2005, 101(6): 1867-1872.
|
| 17 |
Kudoh A, Katagai H, Takazawa T. Anesthesia with ketamine, propofol, and fentanyl decreases the frequency of postoperative psychosis emergence and confusion in schizophrenic patients[J]. J Clin Anesth, 2002, 14(2): 107-110.
|
| 18 |
Preskorn SH, Zeller S, Citrome L, et al. Effect of sublingual dexmedetomidine vs placebo on acute agitation associated with bipolar disorder: a randomized clinical trial[J]. JAMA, 2022, 327(8): 727-736.
|
| 19 |
Liu X, Li Y, Kang L, et al. Recent advances in the clinical value and potential of dexmedetomidine[J]. J Inflamm Res, 2021, 14: 7507-7527.
|
), 吉阳(
